Memorial Şişli Hospital
Memorial Şişli Hospital
Turkey, Istanbul
Dilek Necioglu Orken
37 years of experience
Clinic is certified :
Medication treatment for Parkinson's disease in Turkey typically costs from AUD $1,395 to AUD $2,790. This range usually covers comprehensive diagnostic evaluations and tailored drug therapy plans. Final costs depend on the disease stage and required medication types. To compare, Australians often pay AUD $10,462 for similar care. Travelling to Turkey provides savings of approximately 80% while accessing top neurologists.
Bookimed Expert Insight: Choosing a specialised hub like the Medipol PARMER centre offers unique value. They hold a Guinness World Record for the most Deep Brain Stimulation patients treated. While medication is the first line of defence, these centres provide seamless access to advanced therapies. Specialist Ali Zirh has performed over 1,900 successful interventions for movement disorders. This deep expertise often reduces the long-term trial-and-error costs of drug adjustment.
| Turkey | Thailand | South Korea | |
| Medication treatment for Parkinson's disease | from AUD $1,395 | from AUD $1,116 | from AUD $7,253 |
Associate Professor Ali Zirh is a world-renowned functional neurosurgeon who has performed over 1,600 successful deep brain stimulation (DBS) surgeries.
Dr. Yasar Kutukcu is a neurologist at Anadolu Medical Center in Istanbul. He completed training at the University of California San Francisco. Dr. Kutukcu specializes in Deep Brain Stimulation and movement disorder treatments. He treats complex cases involving Parkinson’s disease, dystonia, and tremors.
Professor Celal Salcini expertly manages movement disorders and dementias at the NP Istanbul Brain Hospital, a facility renowned for high-end neurological care.
Associate Professor Mehmet Tonge is a highly specialised neurosurgeon at the Medipol University Parkinson’s and Movement Disorders Centre, focusing on functional treatments for motor conditions.
In Turkey, the gold-standard Parkinson's disease medication is levodopa with a decarboxylase inhibitor (carbidopa or benserazide). Brand names Sinemet and Madopar are widely available. They are often supplemented with dopamine agonists or MAO-B inhibitors like rasagiline at JCI-accredited centres in Istanbul.
Bookimed Expert Insight: Levodopa is the primary tool. However, Turkish neurologists often combine it with genotyping and drug blood level monitoring. At centres like NP Istanbul Brain Hospital, this personalised approach makes dosing precise. This can reduce side effects compared to standard protocols.
Patient Consensus: Madopar is frequently used in Turkey to effectively treat stiffness and rigidity. Patients find that strict adherence to a specific dosing schedule is essential. It maintains consistent symptom control throughout the day.
Dopamine agonists are a primary mainstream therapy for Parkinson’s disease in Turkey, not merely an alternative. Specialists at JCI-accredited centres like NP Istanbul Brain Hospital use these drugs. They delay levodopa initiation in younger patients. They also manage motor fluctuations in advanced cases.
Bookimed Expert Insight: Turkish neurology centres often provide superior medication personalisation through genetic testing and blood level monitoring. NP Istanbul Brain Hospital specifically offers genotyping to determine how a patient metabolises dopamine agonists. This reduces the risk of impulse control issues common with these medications.
Patient Consensus: Turkish specialists provide clear written plans for these drugs. This is vital for Australians travelling home. Tapering must be gradual to avoid withdrawal. Any behavioural changes require immediate discussion with the medical team.
Patients can access advanced device-assisted therapies for Parkinson's disease in Turkey. They are provided at specialised movement disorder centres. Key interventions include Deep Brain Stimulation (DBS) and MR-guided Focused Ultrasound (MRgFUS). Leading Istanbul facilities provide these high-precision neurological treatments. Examples include Memorial Bahçelievler Hospital and NP Istanbul Brain Hospital.
Bookimed Expert Insight: While general neurology is common, patients should target centres of excellence. These include PARMER or NP Istanbul Brain Hospital. These facilities specialise in functional neurosurgery and use microelectrode recording for high-precision electrode placement. This level of specialisation is critical. It often allows for a significant reduction in long-term medication needs.
Patient Consensus: Patients find Turkey has centres of excellence for movement disorders. They provide accessible surgical options when medication alone fails. The comprehensive care pathway in Istanbul often includes imaging and neuropsychology. It also includes essential long-term device programming.
Enzyme inhibitors support Parkinson's treatment in Turkey by preventing the breakdown of dopamine. They extend the effect of primary medications like levodopa. Turkish neurologists use MAO-B and COMT inhibitors to reduce motor fluctuations and wearing-off symptoms. Specialists at JCI-accredited centres like Memorial Bahçelievler often prescribe these as adjunctive therapies.
Bookimed Expert Insight: Turkish neurology centres like NP Istanbul Brain Hospital use drug blood level monitoring and genotyping. These techniques match enzyme inhibitor dosages to the patient's unique metabolism. This precision reduces the risk of side effects like dyskinesia. It also maximises the time medications remain effective.
Patient Consensus: Patients in Turkey call these boosters. They say the inhibitors extend on-time and prevent the sudden wearing-off of levodopa. Many report improved mobility. This occurs when doctors carefully adjust the timing of each dose to their daily fluctuations.
Parkinson's medications are covered by insurance in Turkey for those enrolled in the public SGK (Sosyal Güvenlik Kurumu) system. Public insurance heavily subsidises standard dopaminergic drugs like Levodopa. International patients without Turkish residency or specific private policies generally pay out of pocket for prescriptions.
Bookimed Expert Insight: Medication management in Turkey costs from $1,000 to $2,000, saving up to 77% compared to Australian averages. SGK provides high coverage for residents. However, international visitors often find Turkish pharmacy retail prices for brands like Madopar significantly cheaper than private prescriptions in Australia.
Patient Consensus: Residents find medications reasonably priced under SGK, but coverage rules for high-cost drugs can change. Australians should bring enough supply for short trips as local reimbursement requires Turkish insurance registration.